Monday, July 14, 2025

Creating liberating content

Many people struggle with constipation and bloating, often triggered by

The early morning hours have long been associated with productivity,

Access Denied You don’t have permission to access ” on

Related News

Many people struggle with constipation and bloating, often triggered by high-fiber foods or supplements. Instead of relying on medications, a natural solution can be found in kiwi. Kiwi is a

Reliance Consumer Products Ltd (RCPL), the fast-moving consumer goods arm of Reliance Industries, has launched its Campa Cola soft drink brand in Nepal, marking its formal entry into the neighbouring

The early morning hours have long been associated with productivity, clarity, and a sense of accomplishment. For many, a morning walk is a cherished ritual that sets the tone for

Access Denied You don’t have permission to access ” on this server. Reference #18.4cfdd417.1752496290.6fb839 Source link

Starting from $158Planning a rail adventure through Italy? Take advantage of the Italy Pass that offers 3 days of unlimited train travel in second class, which can be used within

When it comes to leftovers, it’s essential to prioritise food safety to avoid foodborne illnesses. While many dishes can be safely stored and reheated, some leftovers pose a higher risk

Trending News

Inflation in May 2025 stood at 2.82%. CPI inflation hits over 6-year low! Retail inflation or Consumer Price Index (CPI) inflation for the month of June 2025 has hit an

Access Denied You don’t have permission to access ” on this server. Reference #18.ef277368.1752487505.a8c2 Source link

In a major policy shift, the union ministry of road transport and highways has scrapped the practice of assigning fixed construction targets to states. Instead, it will now work jointly

Access Denied You don’t have permission to access ” on this server. Reference #18.2ef63717.1752482548.176df6 Source link

Top stocks to buy (AI image) Stock market recommendations: According to Motilal Oswal Financial Services Ltd, the top stock picks for the week (starting July 14, 2025) are Suzlon, and

Bitcoin surged past the $120,000 mark for the first time on Monday, setting a new record as optimism grows over potential regulatory clarity in the US.Bitcoin reached a new all-time

Top stocks to buy today: Stock recommendations for March 12, 2025

Word Count: 647 | Estimated Reading Time: 4 minutes


Top stocks to buy today: Stock recommendations for March 12, 2025
Top stocks to buy (AI image)

Stock market recommendations: According to Mehul Kothari, DVP – Technical Research, Anand Rathi Shares and Stock Brokers, Tube Investments, Godrej Agrovet Ltd, and Astrazeneca Pharma are the top stock picks for today:
TUBEINVEST: BUY Near ₹2850 | Stop Loss: ₹2600 | Target: ₹3350
The stock was highly oversold but has started to outperform in the last few days. Most importantly, a change of trend has been confirmed on the short-term charts. Today, a breakout was observed with strong volumes, reinforcing the strength of this move.
Previously, a breakdown occurred around ₹3200–₹3300, and the stock now appears to be preparing for a retest of that zone.
Thus, traders are advised to buy TUBEINVEST in the range of ₹2750–₹2850, with a stop-loss at ₹2600 on a closing basis, for an upside target of ₹3350 in the coming 1–3 months.
GODREJAGRO: BUY ABOVE ₹750 | Stop Loss: ₹700 | Target: ₹850
The stock has significantly outperformed the broader markets and has been consolidating in a range for the past 5–6 months. Based on the current structure, a breakout from this range appears imminent.
With limited downside risk from current levels, traders are advised to buy GODREJAGRO ABOVE ₹750, with a strict stop-loss at ₹700 on a closing basis, for an upside target of ₹850 in the coming 1–3 months.
ASTRAZEN: BUY Near ₹7800 | Stop Loss: ₹7500 | Target: ₹8400
The stock exhibits a structure similar to GODREJAGRO, but even stronger. Today, it delivered a major range breakout, and that too near its lifetime high.
Additionally, RSI has confirmed a breakout, and ADX (14) crossing 28 signals a strengthening trend, indicating the potential for a sharp upside move.
Thus, traders are advised to buy ASTRAZEN in the range of ₹7750–₹7850, with a stop-loss at ₹7500 on a closing basis, for an upside target of ₹8400 in the coming 1–3 months.
Disclaimer: The opinions, analyses and recommendations expressed herein are those of brokerage and do not reflect the views of The Times of India. Always consult with a qualified investment advisor or financial planner before making any investment decisions.





Source link

Most Popular Articles

Sign In

Welcome ! Log into Your Account